TissueTinker Revolutionizes Cancer Research with 3D-Printed Tumors

Published on January 08, 2026 | Translated from Spanish
Microscopic 3D structure of an artificial tumor printed with bioink, showing its complex cellular architecture under laboratory light

When 3D Printing Becomes a Weapon Against Cancer

TissueTinker, originating from McGill University, is changing the game in oncology research. Its 3D-printed tumors, just 300 microns in size, replicate human cancers with unprecedented precision 🧫.

"It's like having a miniature battlefield to test strategies," explains Benjamin Ringler, co-founder of the startup.

Technology That Mimics Life

These innovative models feature:

Bridge Between 3D and Biology

Although they don't use conventional software, their work has parallels with the digital world:

The Future of Clinical Trials

This technology could:

Moral: sometimes the solution to microscopic problems comes from machines that print in 3D. Who would have thought printers would be good for more than making Yoda figurines 🦠.